← 產業報告目錄
RNA Therapy Clinical Trials Market Size, Share & Trends Analysis Report by By Modality (RNA interference, Antisense therapy, Messenger RNA, and Oligonucleotide, non-antisense, non-RNAi), By Phase, By Therapeutic Areas (Rare Diseases, Anti-infective, Anticancer, Neurological), Region And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-20頁數 180報告編號 INSIGHTACE-4b512ef57c
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2024, the RNA Therapy Clinical Trials Market worldwide was assessed at USD 2.5 Bn. Analysts project it will surge to USD 3.6 Bn by 2034, at a CAGR of 3.8% spanning 2025 to 2034.
RNA Therapy Clinical Trials covers The process of testing and evaluating the safety and effectiveness of therapeutic interventions based on RNA molecules is referred to as RNA therapy clinical trials. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Several factors contribute to this trajectory, including heightened interest in next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global RNA Therapy Clinical Trials Market Snapshot
Chapter 4. Global RNA Therapy Clinical Trials Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Modality Estimates & Trend Analysis
5.1. By Modality & Market Share, 2024 -2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Modality:
5.2.1. RNA interference
5.2.2. Antisense therapy
5.2.3. Messenger RNA
5.2.4. Oligonucleotide, non-antisense, non-RNAi
Chapter 6. Market Segmentation 2: By Clinical Trials Phase Estimates & Trend Analysis
6.1. By Modality & Market Share, 2024 -2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Clinical Trials Phase:
6.2.1. Phase I
6.2.2. Phase II
6.2.3. Phase III
6.2.4. Phase IV
Chapter 7. Market Segmentation 3: By Therapeutic Areas Estimates & Trend Analysis
7.1. By Modality & Market Share, 2024 -2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapeutic Areas:
7.2.1. Rare Diseases
7.2.2. Anti-infective
7.2.3. Anticancer
7.2.4. Neurological
7.2.5. Alimentary/Metabolic
7.2.6. Musculoskeletal
7.2.7. Cardiovascular Respiratory
7.2.8. Sensory
7.2.9. Others
Chapter 8. RNA Therapy Clinical Trials Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America RNA Therapy Clinical Trials Market revenue (US$ Million) estimates and forecasts By Modality, 2021-2034
8.1.2. North America RNA Therapy Clinical Trials Market revenue (US$ Million) estimates and forecasts By Clinical Trials Phase, 2021-2034
8.1.3. North America RNA Therapy Clinical Trials Market revenue (US$ Million) estimates and forecasts By Therapeutic Areas, 2021-2034
8.1.4. North America RNA Therapy Clinical Trials Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe RNA Therapy Clinical Trials Market revenue (US$ Million) By Modality, 2021-2034
8.2.2. Europe RNA Therapy Clinical Trials Market revenue (US$ Million) estimates and forecasts By Clinical Trials Phase, 2021-2034
8.2.3. Europe RNA Therapy Clinical Trials Market revenue (US$ Million) estimates and forecasts By Therapeutic Areas 2021-2034
8.2.4. Europe RNA Therapy Clinical Trials Market revenue (US$ Million) by country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific RNA Therapy Clinical Trials Market revenue (US$ Million) by Modality, 2021-2034
8.3.2. Asia Pacific RNA Therapy Clinical Trials Market revenue (US$ Million) estimates and forecasts By Clinical Trials Phase, 2021-2034
8.3.3. Asia Pacific RNA Therapy Clinical Trials Market revenue (US$ Million) estimates and forecasts By Therapeutic Areas, 2021-2034
8.3.4. Asia Pacific RNA Therapy Clinical Trials Market revenue (US$ Million) by country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America RNA Therapy Clinical Trials Market revenue (US$ Million) by Modality, 2021-2034
8.4.2. Latin America RNA Therapy Clinical Trials Market revenue (US$ Million) estimates and forecasts Clinical Trials Phase 2021-2034
8.4.3. Latin America RNA Therapy Clinical Trials Market revenue (US$ Million) estimates and forecasts By Therapeutic Areas, 2021-2034
8.4.4. Latin America RNA Therapy Clinical Trials Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa RNA Therapy Clinical Trials Market revenue (US$ Million) By Modality, (US$ Million)
8.5.2. Middle East & Africa RNA Therapy Clinical Trials Market revenue (US$ Million) estimates and forecasts By Clinical Trials Phase, 2021-2034
8.5.3. Middle East & Africa RNA Therapy Clinical Trials Market revenue (US$ Million) estimates and forecasts By Therapeutic Areas, 2021-2034
8.5.4. Middle East & Africa RNA Therapy Clinical Trials Market revenue (US$ Million) by country, (US$ Million) 2021-2034South Africa
8.5.4.1. GCC Countries
8.5.4.2. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. IQVIA
9.2.2. ICON Plc
9.2.3. Laboratory Corporation of America Holdings
9.2.4. Charles River Laboratories International, Inc.
9.2.5. PAREXEL International Corp.
9.2.6. Syneos Health
9.2.7. Medpace Holdings, Inc.
9.2.8. PPD Inc.
9.2.9. Novotech
9.2.10. Veristat, LLC.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們